IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4138
Positioning
Market Dominance
Retail Trade
Retail
$52M
Matthew N. Hulett
PetMed Express, Inc. operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It sells its products through its Internet website and mobile app, and direct mail/print through catalogs, brochures, and postcards.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = PETS ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$ARCO Arcos Dorados Holdings Inc. | 73 | 85 | 89 | 65 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$IMKTA INGLES MARKETS INC | 70 | 73 | 89 | 76 | 11.3x | 4.1x | 6.9% | 4.1% | 24.3% | 2.8% | 1.9% | -3.4% | 1.1% | 33.0x | $1.2B | VS | |
$SGU STAR GROUP, L.P. | 69 | 82 | 79 | 63 | - | - | -25.2% | -10.6% | 28.1% | -6.3% | -5.4% | -7.8% | 6.1% | 57.0x | $396M | VS | |
$EZPW EZCORP INC | 68 | 77 | 82 | 89 | 7.2x | 4.2x | 12.0% | 6.2% | 59.1% | 11.6% | 8.5% | 10.5% | 0.0% | 52.0x | $764M | VS | |
$HTHT H World Group Ltd | 68 | 91 | 44 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$DDL Dingdong (Cayman) Ltd | 68 | 86 | 82 | 57 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$SBH Sally Beauty Holdings, Inc. | 68 | 83 | 92 | 77 | 5.1x | 2.3x | 32.0% | 6.6% | 51.5% | 8.4% | 4.9% | -1.0% | 0.0% | 178.0x | $934M | VS | |
$SPH SUBURBAN PROPANE PARTNERS LP | 67 | 80 | 90 | 53 | - | 13.0x | 0.4% | -3.5% | 61.7% | 2.1% | -5.7% | 2.2% | 7.1% | 190.0x | $1.2B | VS | |
$IHG INTERCONTINENTAL HOTELS GROUP PLC /NEW/ | 67 | 63 | 81 | 67 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ROST ROSS STORES, INC. | 67 | 63 | 55 | 83 | 25.2x | 16.5x | 34.8% | 13.3% | 28.0% | 11.6% | 9.1% | 10.4% | 1.0% | 26.0x | $51.6B | VS | |
$PETS PETMED EXPRESS INC | 35 | 36 | 28 | 35 | - | - | -164.6% | -61.3% | 27.6% | -28.1% | -28.3% | -29.9% | 0.0% | 168.0x | $52M | ||
| SECTOR BENCH | - | - | - | - | - | 21.4x | 9.1x | 9.6% | 3.6% | 37.3% | 4.4% | 2.4% | 3.7% | 0.0% | 0.7x | - | REF |
PETMED EXPRESS INC (PETS) receives a "Avoid" rating with a composite score of 34.8/100. It ranks #4138 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Average quality profile
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Retail Trade sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
No analyst ratings for PETS.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 36 | 25 | +11ALPHA |
| MOMENTUM | 35 | 31 | +4NEUTRAL |
| VALUATION | 28 | 20 | +8ALPHA |
| INVESTMENT | 35 | 61 | -26DRAG |
| STABILITY | 26 | 16 | +10ALPHA |
| SHORT INT | 41 | 37 | +4NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -164.6% (sector 9.6%)
GM 28% vs sector 37%, OM -28% vs sector 4%
Capital turnover N/A
Rev growth -30%, 11yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate PETMED EXPRESS INC (PETS) as Avoid with a composite score of 34.8/100 at a current price of $2.81. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
PETMED EXPRESS INC holds a top-quartile position (#0 of 50) within the Retail Trade sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 34.8/100 places it at rank #4138 in our full universe.
No Moat
Very High
Poor
Fair Value
Stable competitive position in a defensive sector.
Leverage of 168% D/E amplifies downside risk.
Weak momentum suggests persistent institutional selling pressure.
Vulnerability to macroeconomic shocks and interest rate volatility.
PETMED EXPRESS INC represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags PETMED EXPRESS INC with an Avoid rating, assigning a composite score of 34.8/100 and 1 out of 5 stars. Ranked #4138 of 7,333 stocks, PETS falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
PETS's quality score of 36/100 is below average, suggesting challenges with profitability or capital efficiency. The company reports a return on equity of -164.6% (sector avg: 9.6%), gross margins of 27.6% (sector avg: 37.3%), net margins of -28.3% (sector avg: 2.4%). Investors should examine whether management is actively addressing these weaknesses or if they reflect structural industry headwinds.
PETS registers a value score of just 28/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 1.93x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
PETMED EXPRESS INC's investment score of 35/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of -29.9% vs. a sector average of 3.7% and a return on assets of -61.3% (sector: 3.6%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
PETS is currently showing below-average momentum at 35/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at -29.9% year-over-year, while a beta of 1.00 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
PETS's stability score of 26/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 1.00 and a debt-to-equity ratio of 168.00x (sector avg: 0.7x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 41/100 for PETS suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 168.00x), micro-cap liquidity risk. With a $52M market cap (micro-cap), PETMED EXPRESS INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
PETMED EXPRESS INC is a micro-cap company in the Retail Trade sector, ranked #0 of 50 in its sector (100th percentile) and #4138 of 7,333 overall (44th percentile). Key comparisons include ROE of -164.6% trailing the 9.6% sector median and operating margins of -28.1% below the 4.4% sector average. This top-quartile standing reflects exceptional competitive strength relative to Retail Trade peers.
While PETS currently exhibits a AVOID profile, superior opportunities exist within the RETAIL TRADE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Retail Trade Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Stability (26) would have the largest impact on the composite score.
ROE 1816% BELOW SECTOR MEDIAN
Gross Margin 26% BELOW SECTOR MEDIAN
Op. Margin 743% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
MIAMI BEACH, FLORIDA / ACCESS Newswire / February 12, 2026 / Diveroli Investment Group ("DIG") today announced that it has filed a Schedule 13D with the U.S. Securities and Exchange Commission disclosing a significant ownership position in PetMed ...
Cardone Ventures submitted an unsolicited all-cash proposal of $4.25 per share to acquire PetMed Express, valuing the company at approximately $89 million. The offer targets all outstanding shares and aims to improve the pet pharmacy's performance under private ownership.